ABL Awarded DMID Biologics Manufacturing Contract Worth Up to $102M

ABL Awarded DMID Biologics Manufacturing Contract Worth Up to $102M

  • July 25, 2012

ABL was awarded a 10 year contract with the Division of Microbiology and Infectious Diseases (DMID) to provide “Manufacture and Characterization Services for Vaccines and Other Biologics for Infectious Diseases.”  The contract began July 23, 2012 and has a maximum funding level of $102M. The award announcement can be found on www.fbo.gov.